Telegenetics and COVID 19: Through the Pandemic and Beyond

Published: Thu, 12/09/21

TMT Newly Published Original Research

The November 2021 issue of Telehealth and Medicine Today (TMT) presents readers with original research, reviews and a chorus of growing opinions for change and regulation post pandemic.

Telegenetics and COVID 19: Through the Pandemic and Beyond
Soumiya Ravi et al

Introduction - The COVID 19 pandemic led to restrictions of conventional healthcare delivery. Telemedicine provided a viable solution for social distancing policies imposed to minimize disease transmission. Authors surveyed geneticists across the country to determine their experience and to ascertain if telegenetics will be a lasting change.

Materials and Methods - A 23 item standardized survey was distributed to various US-based geneticists via email and other social media platforms focusing on their experience of providing care via telemedicine.

Conclusion - The future of telemedicine looks promising post-pandemic. Uniform guidelines for use of telemedicine in genetics may need to be proposed by professional societies and supported by federal laws.

Read details at DOI: https://doi.org/10.30953/tmt.v6.295

Submit your original research manuscript to

https://telehealthandmedicinetoday.com/index.php/journal/about/submissions

Deadline for April TMT submissions: March 1, 2022

For a complimentary subscription, register at: https://telehealthandmedicinetoday.com/index.php/journal/user/register

About

Telehealth and Medicine Today (TMT) is a gold open access international peer reviewed journal examining the value of telehealth and clinical automation, its use and scalable developments, business process guidance, market research and the economic impact of digital health innovations in an evolving health technology sector. Articles feature original research, pilot studies, case use, best practices and perspectives from multidisciplinary stakeholders. Authors are encouraged to submit outcomes data for cost efficiencies realized in health system(s), patient populations or clinical practices in a value based system. A world-class review board includes constructive commentary through rapid and rigorous peer review. TMT timestamps article provenance on the blockchain.

TMT’s audience includes leadership at hospitals and medical research centers, universities, payor organizations, IT/IS, healthcare providers, consultants, companies (early and more established), entrepreneurs, developers & start-ups, life sciences and device companies, pharmacy, NGO, government, and policy leadership around the globe.

Endorsed by

Published By

Building Trust Through Truth